Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas

  • Authors:
    • Francesca Orzan
    • Maria Rosa Terreni
    • Mauro Longoni
    • Nicola Boari
    • Pietro Mortini
    • Claudio Doglioni
    • Paola Riva
  • View Affiliations

  • Published online on: July 1, 2007     https://doi.org/10.3892/or.18.1.249
  • Pages: 249-252
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Chordomas are rare neoplasms arising along the axial skeleton. Up to now, the most suitable therapeutic approach is based on a combination of surgical excision and radiotherapy. Chemotherapy in not applied due to its reported low efficacy. Recently, evidence on the efficacy of Imatinib mesylate in two patients has been reported. We analyzed 14 chordoma samples for the expression of the Imatinib mesylate targets by means of RT-PCR and immunohistochemistry and found that PDGFRα and PDGFRβ are in some cases expressed in neoplastic cells, while the stromal counterpart of the same tumor shows the above receptors. Findings on the PDGFA/PDGFB expression suggest a receptor-activated status. Our study provides new insights into the specific localization of Imatinib mesylate targets in skull base chordomas that could be taken into account for the setting up of a pharmacological treatment for this tumor.

Related Articles

Journal Cover

July 2007
Volume 18 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Orzan, F., Terreni, M.R., Longoni, M., Boari, N., Mortini, P., Doglioni, C., & Riva, P. (2007). Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas. Oncology Reports, 18, 249-252. https://doi.org/10.3892/or.18.1.249
MLA
Orzan, F., Terreni, M. R., Longoni, M., Boari, N., Mortini, P., Doglioni, C., Riva, P."Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas". Oncology Reports 18.1 (2007): 249-252.
Chicago
Orzan, F., Terreni, M. R., Longoni, M., Boari, N., Mortini, P., Doglioni, C., Riva, P."Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas". Oncology Reports 18, no. 1 (2007): 249-252. https://doi.org/10.3892/or.18.1.249